Últimos Artículos de Journal of Bone Mineral Research
- Denosumab for the Prevention of Falls in Older People: We Need More Evidence
- Nitrogen‐Containing Bisphosphonates Are Associated With Reduced Risk of Pneumonia in Patients With Hip Fracture
- Role of Platelet C‐Type Lectin‐Like Receptor 2 in Promoting Lung Metastasis in Osteosarcoma
- Skin autofluorescence, a non‐invasive biomarker for advanced glycation end‐products, is associated with prevalent vertebral and major osteoporotic fractures: The Rotterdam Study
- Skin autofluorescence, a non‐invasive biomarker for advanced glycation end‐products, is associated with prevalent vertebral and major osteoporotic fractures: The Rotterdam Study
- Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial
- Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial
- A risk assessment tool for predicting fragility fractures and mortality in the elderly
- A risk assessment tool for predicting fragility fractures and mortality in the elderly
- Macrophage GIT1 contributes to bone regeneration by regulating inflammatory responses in an ERK/NRF2‐dependent way
- Macrophage GIT1 contributes to bone regeneration by regulating inflammatory responses in an ERK/NRF2‐dependent way
- Disruption of BMP signaling prevents hyperthyroidism‑induced bone loss in male mice
- Unique, gender‐dependent serum microRNA profile in PLS3 gene‐related osteoporosis
- Unique, gender‐dependent serum microRNA profile in PLS3 gene‐related osteoporosis
- Disruption of BMP signaling prevents hyperthyroidism‑induced bone loss in male mice
- The amino acid sensor Eif2ak4/GCN2 is required for proliferation of osteoblast progenitors in mice
- The amino acid sensor Eif2ak4/GCN2 is required for proliferation of osteoblast progenitors in mice
- T‐Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial
- T‐Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial
- Circulating Osteocalcin‐Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients